A graph created by University of Minnesota researchers could lead to more treatment options for COVID-19. Researchers compiled information from multiple COVID-19 databases to create the Drug ...

Drug repurposing and discovery represent a transformative approach in modern pharmacology, seeking to identify new therapeutic uses for existing, approved compounds while also uncovering novel drug ...

As of January 27, the global tally of SARS-CoV-2 infections has surpassed 100 million, with fatalities reaching 2 million. Remarkably, approximately 30 million confirmed cases remain untreated with ...

Grant Mitchell thinks most drugs on the market aren’t being used to their full potential, so he launched a company to fix that. Called Every Cure, the Philly-based nonprofit identifies missed ...

My research focuses on developing AI-based computational frameworks for drug discovery, particularly in identifying FDA-approved drugs that can be repurposed to treat complex diseases such as ...

Every Cure is a non-profit that looks to identify new uses for existing drugs and conduct clinical trials of the most promising treatments, while BioPhy is a company that utilizes AI to accelerate the ...

Scientists are using machine learning to find new treatments among thousands of old medicines. Scientists are using machine learning to find new treatments among thousands of old medicines. Joseph ...

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More This post is by Dr. Mukta Paliwal, senior data scientist at Persistent ...

PHILADELPHIA--(BUSINESS WIRE)--BioPhy, an innovative AI drug development company, today announced a partnership with Every Cure, a nonprofit initiative on a mission to unlock the full potential of ...

Finding a new medicine is never easy. But developing treatments for patients with rare diseases — conditions that afflict fewer than 200,000 people in the United States — is particularly challenging.

New Technologies Will Enable Every Cure to Bolster its Computational Drug Development, Drug Repurposing, and Clinical Trial Simulation Efforts – Uncovering More Approved Drugs to Treat Patients ...